Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Nephrology
•
Glomerulonephritis
How would you approach the treatment of crescentic fibrillary glomerulonephritis?
Related Questions
How would you treat idiopathic isolated renal TMA diagnosed on renal biopsy without evidence of MAHA?
What do you feel are the potential barriers to widespread use of obinutuzumab in proliferative lupus nephritis?
How would you approach managing an asymptomatic patient with normal kidney function who has elevated p-ANCA and MPO titers along with evidence for pauci-immune glomerulonephritis on kidney biopsy?
How do you manage nephrotic range proteinuria in a pregnant patient with a known history of diabetic nephropathy prior to pregnancy?
Do you recommend initiating immunosuppression and plasmapheresis in patients with dialysis dependent AKI in the setting of anti-GBM disease who do not have pulmonary involvement?
Do you use delayed-release budesonide over prednisone or methylprednisolone for the treatment of IgA nephropathy, considering the available safety and efficacy data?
What factors do you consider when advising a patient with lupus nephritis on the safety of becoming pregnant?
Under what circumstances would you consider treating with steroid therapy in a patient with HIV-associated nephropathy?
What is your approach to treating IgA nephropathy in patients who also have IgA vasculitis?
How do you approach distinguishing between primary and secondary FSGS in a patient who is PLA2R negative?
